Greenberg Traurig Advises APx Acquisition I in Business Combination Agreement to Create AI-Driven Genomics Company
March 28, 2024
March 28, 2024
MIAMI, Florida, March 28 -- Greenberg Traurig, a law firm, issued the following news release:
Global law firm Greenberg Traurig, P.A. advised APx Acquisition Corp. I, a special purpose acquisition company, in its definitive business combination agreement with OmnigenicsAI Corp, a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd, a UK-based AI-enabled preventive medicine company.
The strategic combination will create a global AI-driven . . .
Global law firm Greenberg Traurig, P.A. advised APx Acquisition Corp. I, a special purpose acquisition company, in its definitive business combination agreement with OmnigenicsAI Corp, a precision medicine company incubated by Bioceres Group PLC, and MultiplAI Health Ltd, a UK-based AI-enabled preventive medicine company.
The strategic combination will create a global AI-driven . . .